PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis.

Elliott, Willie; Guda, Maheedhara R; Asuthkar, Swapna; Teluguakula, Narasaraju; Prasad, Durbaka V R; Tsung, Andrew J; Velpula, Kiran K

Elliott, Willie; Guda, Maheedhara R; Asuthkar, Swapna; Teluguakula, Narasaraju; Prasad, Durbaka V R; Tsung, Andrew J; Velpula, Kiran K.

Afiliación

Elliott W; Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA.
Guda MR; Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA.
Asuthkar S; Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA.
Teluguakula N; VTD Biopharma, Bangalore 560105, India.
Prasad DVR; Department of Microbiology, Yogi Vemana University, Kadapa 516003, India.
Tsung AJ; Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA.
Velpula KK; Department of Neurosurgery, University of Illinois College of Medicine at Peoria, Peoria, IL 61605, USA.

Biomedicines ; 9(12)2021 Dec 09.

Article en En | MEDLINE | ID: mdl-34944683

Palabras clave

COVID-19; NET; PAD; SARS-CoV2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomedicines Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google